Role of Omalizumab in Children With Difficult to Control Asthma

2014 ◽  
Vol 21 (6) ◽  
pp. 247-250
Author(s):  
Judy Pitts ◽  
Shahid I. Sheikh
Keyword(s):  
Author(s):  
Jonathan M. Gaffin ◽  
Mario Castro ◽  
Leonard B. Bacharier ◽  
Anne L. Fuhlbrigge

2012 ◽  
Vol 19 (3) ◽  
pp. 191-192 ◽  
Author(s):  
Louis-Philippe Boulet ◽  
Michel Laviolette

Bronchial thermoplasty is a new technique proposed to improve control of moderate to severe asthma. It delivers thermal energy to the large airways during a bronchoscopy to decrease the amount of bronchial smooth muscle. This intervention has been shown to reduce asthma exacerbations, and improve asthma control and quality of life over a three-year period without significant complications up to a five-year period. It could be considered as another option in the treatment of selected patients requiring oral and/or high doses of inhaled corticosteroids to control asthma. It should, however, be performed in specialized centres in patients who understand the potential benefits and side-effects of this technique. The response to this treatment varies from one patient to another. Consequently, further studies are required to better define the role of this option in the treatment of asthma.


Author(s):  
Anand Shah ◽  
Andrew Menzies-Gow

Poorly controlled asthma is a common reason for referral to the respiratory clinic, and the majority of cases can be managed effectively by ensuring the correct diagnosis and ensuring good compliance with inhaled therapy. However, severe asthma affects up to 10% of patients with asthma and is associated with substantial morbidity and mortality, along with significant health-care costs from both inpatient treatment and lost work days. This chapter covers two cases of difficult-to-control asthma and highlights the role of detailed investigations when asthma control is not straightforward. It will cover the diagnostic criteria for allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization and discuss the role of omalizumab in managing severe asthma.


2020 ◽  
Vol Volume 13 ◽  
pp. 625-632
Author(s):  
Pei-Wen Wu ◽  
Ta-Jen Lee ◽  
Chun-Hua Wang ◽  
Chi-Che Huang ◽  
Po-Hung Chang ◽  
...  

2011 ◽  
pp. 101-108 ◽  
Author(s):  
A. V. Budnevsky ◽  
V. T. Burlachuk ◽  
I. A. Olysheva ◽  
E. V. Tokmachev
Keyword(s):  

Nutrients ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 3708
Author(s):  
Valeria Calcaterra ◽  
Elvira Verduci ◽  
Michele Ghezzi ◽  
Hellas Cena ◽  
Martina Chiara Pascuzzi ◽  
...  

Childhood obesity rates have dramatically risen in numerous countries worldwide. Obesity is likely a factor in increased asthma risk, which is already one of the most widespread chronic respiratory pathologies. The pathogenic mechanism of asthma risk has still not yet been fully elucidated. Moreover, the role of obesity-related inflammation and pulmonary overreaction to environmental triggers, which ultimately result in asthma-like symptoms, and the importance of dietary characteristics is well recognized. Diet is an important adjustable element in the asthma development. Food-specific composition of the diet, in particular fat, sugar, and low-quality nutrients, is likely to promote the chronic inflammatory state seen in asthmatic patients with obesity. An unbalanced diet or supplementation as a way to control asthma more efficiently has been described. A personalized dietary intervention may improve respiratory symptoms and signs and therapeutic response. In this narrative review, we presented and discussed more recent literature on asthma associated with obesity among children, focusing on the risk of asthma among children with obesity, asthma as a result of obesity focusing on the role of adipose tissue as a mediator of systemic and local airway inflammation implicated in asthma regulation, and the impact of nutrition and nutrients in the development and treatment of asthma. Appropriate early nutritional intervention could possibly be critical in preventing and managing asthma associated with obesity among children.


2001 ◽  
Vol 28 (6) ◽  
pp. 769-782 ◽  
Author(s):  
Noreen M. Clark ◽  
Molly Gong ◽  
Niko Kaciroti

Chronic disease poses increasing threat to individual and community health. The day-to-day manager of disease is the patient who undertakes actions with the guidance of a clinician. The ability of the patient to control the illness through an effective therapeutic plan is significantly influenced by social and behavioral factors. This article presents a model of patient management of chronic disease that accounts for intrapersonal and external influences on management and emphasizes the central role of self-regulatory processes in disease control. Asthma serves as a case for exploration of the model. Findings from a 5-year study of 637 children with asthma and their care-taking parents supported that the self-regulation elements of the model were reasonably stable over time and baseline values were predictive of important disease management outcomes.


JAMA ◽  
1966 ◽  
Vol 195 (12) ◽  
pp. 1005-1009 ◽  
Author(s):  
D. J. Fernbach
Keyword(s):  

JAMA ◽  
1966 ◽  
Vol 195 (3) ◽  
pp. 167-172 ◽  
Author(s):  
T. E. Van Metre

Sign in / Sign up

Export Citation Format

Share Document